Correction: The lipid-transfer protein Nir2 enhances epithelial-mesenchymal transition and facilitates breast cancer metastasis (Journal of Cell Science (2014) 127 (4740-4749) DOI: 10.1242/jcs.155721);The lipid-transfer protein Nir2 enhances epithelial-mesenchymal transition and facilitates breast cancer metastasis

Journal of Cell Science

Volumn 127, Issue 21, 2014, Pages 4740-4749

  Keinan, Omer ^a   Kedan, Amir ^a   Gavert, Nancy ^a   Selitrennik, Michael ^a   Kim, SoHui ^a   Karn, Thomas ^b   Becker, Sven ^b   Lev, Sima ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

EMT; Invasion; Metastasis; Migration; Nir2; PITPNM1

Indexed keywords

LIPID TRANSFER PROTEIN; LIPID TRANSFER PROTEIN NIR2; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; EYE PROTEIN; MEMBRANE PROTEIN; PITPNM PROTEIN, MOUSE; PITPNM1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER PROGNOSIS; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MOUSE; NONHUMAN; ANIMAL; BREAST TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; EYE PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; MICE; NEOPLASM INVASIVENESS;

EID: 84913570618     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.227868     Document Type: Erratum

References (54)

1. Amarilio, R., Ramachandran, S., Sabanay, H. and Lev, S. (2005). Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. J. Biol. Chem. 280, 5934-5944.
2. Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L. and Arteaga, C. L. (2000). Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275, 36803-36810.
3. Bartucci, M., Morelli, C., Mauro, L., Andò, S. and Surmacz, E. (2001). Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Res. 61, 6747-6754.
4. Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J. and García De Herreros, A. (2000). The transcription factor snail is a repressor of Ecadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2, 84-89.
5. Bellacosa, A. L. L. (2010). PI3K/AKT pathway and the epithelial-mesenchymal transition. In Cancer Genome and Tumor Microenvironment (ed. T. Tikhonenko-Andrei), pp. 11-21. New York, NY: Springer.
6. Bolós, V., Peinado, H., Pérez-Moreno, M. A., Fraga, M. F., Esteller, M. and Cano, A. (2003). The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci. 116, 499-511.
7. Brabletz, T. (2012). EMTand MET in metastasis: where are the cancer stem cells? Cancer Cell 22, 699-701.
8. Brown, R. L., Reinke, L. M., Damerow, M. S., Perez, D., Chodosh, L. A., Yang, J. and Cheng, C. (2011). CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J. Clin. Invest. 121, 1064-1074.
9. Cancer Genome Atlas Network (2012). Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70.
10. Chang, C. L., Hsieh, T. S., Yang, T. T., Rothberg, K. G., Azizoglu, D. B., Volk, E., Liao, J. C. and Liou, J. (2013). Feedback regulation of receptor-induced Ca2+ signaling mediated by E-Syt1 and Nir2 at endoplasmic reticulum-plasma membrane junctions. Cell Reports 5, 813-825.
11. Cho, S. J., Chae, M. J., Shin, B. K., Kim, H. K. and Kim, A. (2008). Akt-and MAPK-mediated activation and secretion of MMP-9 into stroma in breast cancer cells upon heregulin treatment. Mol. Med. Rep. 1, 83-88.
12. Curtis, C., Shah, S. P., Chin, S. F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., Yuan, Y. et al.; METABRIC Group (2012). The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346-352.
13. Gan, B., Sahin, E., Jiang, S., Sanchez-Aguilera, A., Scott, K. L., Chin, L., Williams, D. A., Kwiatkowski, D. J. and DePinho, R. A. (2008). mTORC1-dependent and-independent regulation of stem cell renewal, differentiation, and mobilization. Proc. Natl. Acad. Sci. USA 105, 19384-19389.
14. Grille, S. J., Bellacosa, A., Upson, J., Klein-Szanto, A. J., van Roy, F., Lee-Kwon,W., Donowitz, M., Tsichlis, P. N. and Larue, L. (2003). The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 63, 2172-2178.
15. Gupta, G. P. and Massagué, J. (2006). Cancer metastasis: building a framework. Cell 127, 679-695.
16. Hardy, K. M., Booth, B. W., Hendrix, M. J., Salomon, D. S. and Strizzi, L. (2010). ErbB/EGF signaling and EMT in mammary development and breast cancer. J. Mammary Gland Biol. Neoplasia 15, 191-199.
17. Harrison, S. M., Knifley, T., Chen, M. and O'Connor, K. L. (2013). LPA, HGF, and EGF utilize distinct combinations of signaling pathways to promote migration and invasion of MDA-MB-231 breast carcinoma cells. BMC Cancer 13, 501.
18. Hollestelle, A., Elstrodt, F., Nagel, J. H., Kallemeijn, W. W. and Schutte, M. (2007). Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines. Mol. Cancer Res. 5, 195-201.
19. Huber, M. A., Kraut, N. and Beug, H. (2005). Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17, 548-558.
20. Imamura, T., Hikita, A. and Inoue, Y. (2012). The roles of TGF-b signaling in carcinogenesis and breast cancer metastasis. Breast Cancer 19, 118-124.
21. Irie, H. Y., Pearline, R. V., Grueneberg, D., Hsia, M., Ravichandran, P., Kothari, N., Natesan, S. and Brugge, J. S. (2005). Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J. Cell Biol. 171, 1023-1034.
22. Iwatsuki, M., Mimori, K., Yokobori, T., Ishi, H., Beppu, T., Nakamori, S., Baba, H. and Mori, M. (2010). Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 101, 293-299.
23. Khanna, C. and Hunter, K. (2005). Modeling metastasis in vivo. Carcinogenesis 26, 513-523.
24. Kim, E. S., Kim, M. S. and Moon, A. (2004). TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int. J. Oncol. 25, 1375-1382.
25. Kim, S., Kedan, A.,Marom,M., Gavert, N., Keinan, O., Selitrennik,M., Laufman, O. and Lev, S. (2013). The phosphatidylinositol-transfer proteinNir2 binds phosphatidic acid and positively regulates phosphoinositide signalling. EMBO Rep. 14, 891-899.
26. Köhrmann, A., Kammerer, U., Kapp, M., Dietl, J. and Anacker, J. (2009). Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: new findings and review of the literature. BMC Cancer 9, 188.
27. Kraus, J. A., Dabbs, D. J., Beriwal, S. and Bhargava, R. (2012). Semiquantitative immunohistochemical assay versus oncotype DX((R)) qRT-PCR assay for estrogen and progesterone receptors: an independent quality assurance study. Mod. Pathol. 25, 869-876.
28. Lee, T. K., Poon, R. T., Yuen, A. P., Ling, M. T., Kwok, W. K., Wang, X. H., Wong, Y. C., Guan, X. Y., Man, K., Chau, K. L. et al. (2006). Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin. Can. Res. 12, 5369-5376.
29. Lev, S. (2004). The role of the Nir/rdgB protein family in membrane trafficking and cytoskeleton remodeling. Exp. Cell Res. 297, 1-10.
30. Lev, S., Hernandez, J., Martinez, R., Chen, A., Plowman, G. and Schlessinger, J. (1999). Identification of a novel family of targets of PYK2 related to Drosophila retinal degeneration B (rdgB) protein. Mol. Cell. Biol. 19, 2278-2288.
31. Litvak, V., Dahan, N., Ramachandran, S., Sabanay, H. and Lev, S. (2005). Maintenance of the diacylglycerol level in the Golgi apparatus by the Nir2 protein is critical for Golgi secretory function. Nat. Cell Biol. 7, 225-234.
32. Lo, H. W., Hsu, S. C., Xia, W., Cao, X., Shih, J. Y., Wei, Y., Abbruzzese, J. L., Hortobagyi, G. N. and Hung, M. C. (2007). Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 67, 9066-9076.
33. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
34. Oppenheimer, S. B. (2006). Cellular basis of cancer metastasis: a review of fundamentals and new advances. Acta Histochem. 108, 327-334.
35. Pal, I. and Mandal, M. (2012). PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes. Acta Pharmacol. Sin. 33, 1441-1458.
36. Peretti, D., Dahan, N., Shimoni, E., Hirschberg, K. and Lev, S. (2008). Coordinated lipid transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential for Golgi-mediated transport. Mol. Biol. Cell 19, 3871-3884.
37. Price, J. T., Tiganis, T., Agarwal, A., Djakiew, D. and Thompson, E. W. (1999). Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 39-kinase and phospholipase C-dependent mechanism. Cancer Res. 59, 5475-5478.
38. Rao, M., Song, W., Jiang, A., Shyr, Y., Lev, S., Greenstein, D., Brantley-Sieders, D. and Chen, J. (2012). VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity. PLoS ONE 7, e46281.
39. Rashid, O. M., Nagahashi, M., Ramachandran, S., Dumur, C. I., Schaum, J. C., Yamada, A., Aoyagi, T., Milstien, S., Spiegel, S. and Takabe, K. (2013). Is tail vein injection a relevant breast cancer lung metastasis model? J. Thorac. Dis. 5, 385-392.
40. Romagnoli, M., Belguise, K., Yu, Z., Wang, X., Landesman-Bollag, E., Seldin, D. C., Chalbos, D., Barillé-Nion, S., Jézéquel, P., Seldin, M. L. et al. (2012). Epithelial-to-mesenchymal transition induced by TGF-b1 is mediated by Blimp-1-dependent repression of BMP-5. Cancer Res. 72, 6268-6278.
41. Savagner, P. (2001). Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. BioEssays 23, 912-923.
42. Savagner, P. (2010). The epithelial-mesenchymal transition (EMT) phenomenon. Ann. Oncol. 21 Suppl. 7, vii89-92.
43. Somiari, S. B., Somiari, R. I., Heckman, C. M., Olsen, C. H., Jordan, R. M., Russell, S. J. and Shriver, C. D. (2006). Circulating MMP2 and MMP9 in breast cancer -potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int. J. Cancer 119, 1403-1411.
44. Su, S. C., Mendoza, E. A., Kwak, H. I. and Bayless, K. J. (2008). Molecular profile of endothelial invasion of three-dimensional collagen matrices: insights into angiogenic sprout induction in wound healing. Am. J. Physiol. 295, C1215-C1229.
45. Tarcic, G., Avraham, R., Pines, G., Amit, I., Shay, T., Lu, Y., Zwang, Y., Katz, M., Ben-Chetrit, N., Jacob-Hirsch, J. et al. (2012). EGR1 and the ERKERF axis drive mammary cell migration in response to EGF. FASEB J. 26, 1582-1592.
46. Têtu, B., Brisson, J., Wang, C. S., Lapointe, H., Beaudry, G., Blanchette, C. and Trudel, D. (2006). The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis. Breast Cancer Research 8, R28.
47. Thiery, J. P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454.
48. Thiery, J. P. and Sleeman, J. P. (2006). Complex networks orchestrate epithelialmesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7, 131-142.
49. Thiery, J. P., Acloque, H., Huang, R. Y. and Nieto, M. A. (2009). Epithelialmesenchymal transitions in development and disease. Cell 139, 871-890.
50. Tian, D., Litvak, V., Toledo-Rodriguez, M., Carmon, S. and Lev, S. (2002). Nir2, a novel regulator of cell morphogenesis. Mol. Cell. Biol. 22, 2650-2662.
51. Tsai, M. S., Shamon-Taylor, L. A., Mehmi, I., Tang, C. K. and Lupu, R. (2003). Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer. Oncogene 22, 761-768.
52. Tumbarello, D. A. and Turner, C. E. (2007). Hic-5 contributes to epithelialmesenchymal transformation through a RhoA/ROCK-dependent pathway. J. Cell. Physiol. 211, 736-747.
53. Whyte, J., Bergin, O., Bianchi, A., McNally, S. and Martin, F. (2009). Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development. Breast Cancer Research 11, 209.
54. Xiao, D. and He, J. (2010). Epithelial mesenchymal transition and lung cancer. J. Thorac. Dis. 2, 154-159.